The human cytomegalovirus UL97 protein is phosphorylated and a component of virions

Virology

Volumn 231, Issue 1, 1997, Pages 72-80

  Van Zeijl, Marja ^a   Fairhurst, Jeanette ^a   Baum, Ellen Z ^a   Sun, Lei ^a   Jones, Thomas R ^a  

^a PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GANCICLOVIR; PHOSPHOPROTEIN; VIRUS PROTEIN;

ARTICLE; BIOSYNTHESIS; CONTROLLED STUDY; CYTOMEGALOVIRUS; DRUG EFFECT; NONHUMAN; OPEN READING FRAME; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; VIRION;

CYTOMEGALOVIRUS; HUMAN HERPESVIRUS 5;

EID: 0030955930     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1997.8523     Document Type: Article

References (54)

1. Alain S., Mazeron M-C., Pepin J-M., Morinet F., Raskine L., Sanson-Le Pors M-J. Rapid detection of cytomegalovirus strains resistant to ganciclovir through mutations within the gene UL97. Mol. Cell. Probes. 7:1993;487-495.
2. Baldick C. J., Shenk T. Proteins associated with purified human cytomegalovirus particles. J. Virol. 70:1996;6097-6105.
3. Biron K. K., Stanat S. C., Sorrell J. B., Fyfe J. A., Keller P. M., Lambe C. U., Nelson D. J. Metabolic activation of the nucleoside analog 9-{[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl}guanine in human diploid fibroblasts infected with human cytomegalovirus. Proc. Natl. Acad. Sci. USA. 83:1985;8769-8773.
4. Britt W. J., Alford C. A. Cytomegalovirus. Virology. 1996;Raven Press, New York. p. 2493-2524.
5. Britt W. J., Auger D. Human cytomegalovirus virion-associated protein with kinase activity. J. Virol. 59:1986;185-188.
6. Chee M. S., Bankier A. T., Beck S., Bohni R., Brown C. M., Cerny R., Horsnell T., Hutchison III C. A., Kouzarides T., Martignetti J. A., Preddie E., Satchwell S. C., Tomlinson P., Weston K. M., Barrell B. G. Analysis of the protein-coding content of the sequence of human cytomegalovirus strain AD169. Curr. Topics Microbiol. Immunol. 154:1990;125-169.
7. Chee M. S., Lawrence G. L., Barrell B. G. Alpha-, beta-, and gammaherpesviruses encode a putative phosphotransferase. J. Gen. Virol. 70:1989;1151-1160.
8. Cheng Y. C., Grill S. P., Dutschman G. E., Nakayama K., Bastow K. F. Metabolism of 9-(1,3-dihydroxy-2-propoxymethyl)guanine, a new anti-herpes virus compound, in herpes simplex-infected cells. J. Biol. Chem. 258:1983;12460-12464.
9. Chou S., Guentzel K. R., Michels S., Miner R. C., Drew W. L. Frequency of UL97 phosphotransferase mutations related to ganciclovir resistance in clinical cytomegalovirus isolates. J. Inf. Dis. 172:1995;239-242.
10. Cohen G. H., Ponce de Leon M., Diggelmann H., Lawrence W. C., Vernon S. K., Eisenberg R. J. Structural analysis of the capsid polypeptides of herpes simplex virus types 1 and 2. J. Virol. 34:1980;521-531.
11. Compton T. An immortalized human fibroblast cell line is permissive for human cytomegalovirus infection. J. Virol. 67:1993;3644-3648.
12. Crumpacker C. S. Ganciclovir. New Engl. J. Med. 335:1996;721-729.
13. Cunningham C., Davison A. J., Dolan A., Frame M. C., McGeoch D. J., Meredith D. M., Moss H. W. M., Orr A. C. The UL13 virion protein of herpes simplex virus type 1 is phosphorylated by a novel virus-induced protein kinase. J. Gen. Virol. 73:1992;303-311.
14. de la Luna S., Ortin J. pac. Methods Enzymol. 216:1992;376-385.
15. Depto A. S., Stenberg R. M. Regulated expression of the human cytomegalovirus pp65 gene: octamer sequence in the promoter is required for activation by viral gene products. J. Virol. 63:1989;1232-1238.
16. Efstathiou S., Kemp S., Darby G., Minson A. C. The role of herpes simplex virus type 1 thymidine kinase in pathogenesis. J. Gen. Virol. 70:1989;869-879.
17. Fyfe J. A., Keller P. M., Furman P. A., Miller R. L., Elion G. B. Thymidine kinase from herpes simplex virus phosphorylates the new antiviral compound, 9-(2-hydroxyethoxymethyl)guanine. J. Biol. Chem. 253:1978;8721-8727.
18. Gibson W., Roizman B. Proteins specified by herpes simplex virus. 8. Characterization and composition of multiple capsid forms of subtypes 1 and 2. J. Virol. 10:1972;1044-1052.
19. Gilbert M. J., Riddell S. R., Plachter B., Greenberg P. D. Cytomegalovirus selectively blocks antigen processing and presentation of its immediate-early gene product. Nature. 383:1996;720-722.
20. Grässer F. A., Haiss P., Gottel S., Mueller-Lantzsch N. Biochemical characterization of Epstein-Barr virus nuclear antigen 2A. J. Virol. 65:1991;3779-3788.
21. Grässer F. A., Konig S. Phosphorylation of SV40 large T antigen at threonine residues results in conversion to a lower apparent molecular weight form. Arch. Virol. 126:1992;313-320.
22. Hanks S. K., Quinn A. M., Hunter T. The protein kinase family: conserved features and deduced phylogeny of the catalytic domains. Science. 241:1988;42-52.
23. He Z., He Y-S., Kim Y., Chu L., Ohmstede C., Biron K. K., Coen D. M. The human cytomegalovirus UL97 protein is a protein kinase that autophosphorylates on serines and threonines. J. Virol. 71:1996;405-411.
24. Irmiere A., Gibson W. Isolation and characterization of a noninfectious virion-like particle released from cells infected with human strains of cytomegalovirus. Virology. 130:1983;118-133.
25. Irmiere A., Gibson W. Isolation of human cytomegalovirus intranuclear capsids, characterization of their protein constituents, and demonstration that the B-capsid assembly protein is also abundant in noninfectious enveloped particles. J. Virol. 56:1985;277-283.
26. Jones T. R., Muzithras V. P., Gluzman Y. Replacement mutagenesis of the human cytomegalovirus genome: US10 and US11 gene products are nonessential. J. Virol. 65:1991;5860-5872.
27. Jones T. R., Sun L., Bebernitz G. A., Muzithras V. P., Kim H-J., Johnston S. H., Baum E. Z. Proteolytic activity of human cytomegalovirus UL80 protease cleavage site mutations. J. Virol. 68:1994;3742-3752.
28. Jones T. R., Hanson L. K., Sun L., Slater J. S., Stenberg R. M., Campbell A. E. Multiple independent loci within the human cytomegalovirus unique short region down-regulate expression of major histocompatibility complex class I heavy chains. J. Virol. 69:1995;4830-4841.
29. Kim H-J., Gatz C., Hillen W., Jones T. R. Tetracycline repressor-regulated gene expression in recombinant human cytomegalovirus. J. Virol. 69:1995;2565-2573.
30. Kozak M. An analysis of vertebrate mRNA sequences: Intimations of translational control. J. Cell Biol. 115:1991;887-903.
31. Lawrence G. L., Chee M., Craxton M. A., Gompels U. A., Honess R. W., Barrell B. G. Human herpesvirus 6 is closely related to human cytomegalovirus. J. Virol. 64:1990;287-299.
32. Littler E., Stuart A. D., Chee M. S. Human cytomegalovirus UL97 open reading frame encodes a protein that phosphorylates the antiviral nucleoside analog ganciclovir. Nature. 358:1992;160-162.
33. Liu B., Stinski M. F. Human cytomegalovirus contains a tegument protein that enhances transcription from promoters with upstream ATF and AP-1cis. J. Virol. 66:1992;4434-4444.
34. Mar E. C., Chiou J. F., Cheng Y. C., Huang E.-S. Inhibition of cellular DNA polymerase alpha and human cytomegalovirus-induced DNA polymerase by the triphosphates of 9-(2-hydroxyethoxymethyl)guanine and 9-(1,3-dihydroxy-2-propoxymethyl)guanine. J. Virol. 53:1985;776-780.
35. Metzger C., Michel D., Schneider K., Luske A., Schlicht H-J., Mertens T. Human cytomegalovirus UL97 kinase confers ganciclovir susceptibility to recombinant vaccinia virus. J. Virol. 68:1994;8423-8427.
36. Michel D., Pavic I., Zimmerman A., Haupt E., Wunderlich K., Heuschmid M., Mertens T. The UL97 product of human cytomegalovirus is an early-late protein with a nuclear localization but is not a nucleoside kinase. J. Virol. 70:1996;6340-6346.
37. Michelsen S., Tardy-Panit M., Bârzu O. Properties of a human cytomegalovirus-induced protein kinase. Virology. 134:1984;259-268.
38. Ng T. I., Talarico C., Burnette T. C., Biron K., Roizman B. Partial substitution of the functions of the herpes simplex virus 1 UL13 gene by the human cytomegalovirus UL97 gene. Virology. 225:1996;347-358.
39. Oram J. D., Downing R. G., Akrigg A., Dollery A. A., Duggleby C. J., Wilkinson G. W. G., Greenaway P. J. Use of recombinant plasmids to investigate the structure of the human cytomegalovirus genome. J. Gen. Virol. 59:1982;111-129.
40. Overton H. A., McMillan D. J., Klavinskis L. S., Hope L., Ritchie A. J., Wong-Kai-In P. Herpes simplex virus type 1 gene UL13 encodes a phosphoprotein that is a component of the virion. Virology. 190:1992;184-192.
41. Plotch S. J., Palant O., Gluzman Y. Purification and properties of poliovirus RNA polymerase expressed inEscherichia coli. J. Virol. 63:1989;216-225.
42. Purves F. C., Roizman B. The UL13 gene of herpes simplex virus 1 encodes the functions for posttranslational processing associated with phosphorylation of the regulatory protein alpha 22. Proc. Natl. Acad. Sci. USA. 89:1992;7310-7314.
43. Purves F. C., Ogle W. O., Roizman B. Processing of the herpes simplex virus regulatory protein alpha 22 mediated by the UL13 protein kinase determines the accumulation of a subset of alpha and gamma mRNAs and proteins in infected cells. Proc. Natl. Acad. Sci. USA. 90:1993;6701-6705.
44. Rixon F. J., Davison M. D., Davison A. J. Identification of the genes encoding two capsid proteins of herpes simplex virus type 1 by direct amino acid sequencing. J. Gen. Virol. 71:1990;1211-1214.
45. Roby C., Gibson W. Characterization of phosphoproteins and protein kinase activity of virions, noninfectious enveloped particles, and dense bodies of human cytomegalovirus. J. Virol. 59:1986;714-727.
46. Roizman B., Sears A. E. Herpes simplex viruses and their replication. Roizman B., Whitley R. J., Lopez C. The Human Herpesviruses. 1993;11-68 Raven Press, New York.
47. Sambrook J., Fritsch E. F., Maniatis T. Molecular Cloning: A Laboratory Manual. 1989;Cold Spring Harbor Laboratory Press, Cold Spring Harbor.
48. Schmolke S., Kern H. F., Drescher P., Jahn G., Plachter B. The dominant phosphoprotein pp65 (UL83) of human cytomegalovirus is dispensable for growth in cell culture. J. Virol. 69:1995;5959-5968.
49. Smith R. F., Smith T. F. Identification of new protein kinase-related genes in three herpes viruses, herpes simplex virus, varicella-zoster virus, and Epstein-Barr virus. J. Virol. 63:1989;450-455.
50. Sullivan V., Talarico C. L., Stanat S. C., Davis M., Coen D. M., Biron K. K. A protein kinase homologue controls phosphorylation of ganciclovir in human cytomegalovirus-infected cells. Nature. 358:1992;162-164.
51. Sullivan V., Biron K. K., Talarico C., Stanat S. C., Davis M., Pozzi L. M., Coen D. M. A point mutation in the human cytomegalovirus DNA polymerase gene confers resistance to ganciclovir and phosphonylmethoxyalkyl derivatives. Antimicr. Agents Chemother. 37:1993;19-25.
52. Talbot P., Almeida J. D. Human cytomegalovirus: purification of enveloped virions and dense bodies. J. Gen. Virol. 36:1977;345-349.
53. Ward P. L., Ogle W. O., Roizman B. Assemblons: Nuclear structures defined by aggregation of immature capsids and some tegument proteins of herpes simplex virus. J. Virol. 70:1996;4623-4631.
54. Wing B. A., Huang E-S. Analysis and mapping of a family of 3′-coterminal transcripts containing coding sequences for human cytomegalovirus open reading frames UL93 through UL99. J. Virol. 69:1995;1521-1531.